51 results about "Herba Scutellariae Barbatae" patented technology

A traditional Chinese medicine composition for treating pulmonary nodules, wherein the composition is prepared from the following traditional Chinese medicines in parts by weight: a principle drug selected from one or more of 10-45 parts of raw Astragali radix, 10-25 parts of Sargassum, and 10-25 parts of Arisaematis rhizoma preparatum; a minister drug selected from one or more of 10-25 parts of Fritillariae thunbergii bulbus, 10-25 parts of Forsythiae fructus, 10-25 parts of stir-fried Atractylodis macrocephalae rhizoma, 1T0 part of Hirudo, 10-25 parts of Dioscoreae nipponicae rhizoma, 10-35 parts of Adenophorae radix, 10-35 parts of honey-processed Mori cortex, 10-25 parts of Perillae fructus, 10-25 parts of Peucedani radix, 10-35 parts of Phragmitis rhizome, 10-45 parts of raw Coicis semen, 5-25 parts of vinegar-processed Cyperi rhizoma, 10-25 parts of Aurantii fructus, 10-25 parts of Paeoniae radix alba, 10-35 parts of Scutellariae barbatae herba, 10-35 parts of Herba duchesneae indicae, 10-35 parts of Salviae chinensis herba, 5-20 parts of Menispermi rhizoma, 5-20 parts of Momordicae semen, 10-25 parts of Curcumae rhizoma, and 5-20 parts of Gleditsiae spina; an assistant drug selected from one or more of 5-25 parts of vinegar-processed Bupleuri radix, 5-25 parts of Citri reticulatae pericarpium, 10-25 parts of Perillae fructus, 2-12 parts of processed Ephedrae herba, 10-25 parts of Cynanchi stauntonii rhizoma et radix, 5-20 parts of Typhonii rhizoma, 2-12 parts of Zingiberis rhizoma, 10-35 parts of Morindae officinalis radix, 10-35 parts of Scutellariae barbatae herba, 10-45 parts of Radix aconiti lateralis praeparata nigra, and 10-25 parts of Typhonii rhizoma praeparata; and an envoy drug selected from one or more of 5-20 parts of Fagopyri dibotryis rhizoma, 10-25 parts of Platycodonis radix, 10-25 parts of Paeoniae radix alba, and 5-25 parts of Glycyrrhizae radix et rhizoma praeparata cum melle.

The invention belongs to the technical field of biological medicines, and particularly relates to a traditional Chinese medicine composition for treating metabolism-related fatty liver diseases and a preparation method thereof. The technical problem to be solved by the invention is to provide a new choice for treating metabolism-related fatty liver diseases. According to the technical scheme, the traditional Chinese medicine composition for treating the metabolism-related fatty liver disease is prepared from the following components: radix paeoniae rubra, cyrtomium fortunei, curcuma zedoary, sculellaria barbata, herba epimedii, fingered citron, semen cassiae and herba artemisiae scopariae. The invention is mainly used for providing a new choice for treating the metabolism-related fatty liver disease, and has a wide application prospect.

The use of a Reyanning formulation in the preparation of a drug for preventing and treating prostatitis. The Reyanning formulation is prepared from dandelion, giant knotweed rhizome, sonchi arvensis herba and herba scutellariae barbatae. The present application finds that the Reyanning formulation can reduce the contents of IL-6, IL-1β, NO and MDA in the serum of model rats, HE staining results show that the Reyanning formulation has certain relieving effect on the damage of prostate tissue, and it can be concluded from the molecular and tissue levels that the Reyanning formulation has certain prevention and treatment effect on chronic non-bacterial prostatitis.

The invention relates to the technical field of cordyceps sinensis, and particularly discloses cordyceps sinensis sporocarp electuary as well as a preparation method and application thereof. The medicinal material formula of the cordyceps sinensis sporocarp electuary is prepared from the following raw materials by weight: 35 to 45 g of cordyceps sinensis sporocarp powder, 16 to 22 g of radix ophiopogonis, 15 to 20 g of radix asparagi, 10 to 15 g of radix glehniae, 10 to 15 g of radix adenophorae, 25 to 35 g of rhizoma polygonati, 26 to 32 g of radix astragali seu hedysari, 10 to 15 g of radix angelicae sinensis, 25 to 34 g of caulis spatholobi, 25 to 30 g of solanum lyratum, 15 to 25 g of herba scutellariae barbatae, 25 to 30 g of oldenlandia diffusa, 25 to 35 g of salvia chinensis, 25 to 30 g of raw malt, 25 to 30 g of rice sprout, 25 to 30 g of medicated leaven and 8 to 12 g of periostracum cicadae. The cordyceps sinensis sporocarp electuary can be used for treating lung cancer, and has the advantages of strengthening the body resistance, resisting cancer and decomposing tumors.

The invention provides a traditional Chinese medicine composition, a preparation method and application thereof and a pharmaceutical composition. The traditional Chinese medicine composition comprises radix pseudostellariae, astragalus membranaceus, sculellaria barbata, houttuynia cordata, radix bupleuri, semen coicis, rhizoma polygonati, platycodon grandiflorum and liquorice. The traditional Chinese medicine composition provided by the invention is high in safety, long in application period, outstanding in immune regulation function, low in drug resistance risk, remarkable in comprehensive curative effect, wide in adaptation disease range and flexible in clinical application, and multiple mechanisms are cooperated.

The invention discloses a traditional Chinese medicine composition for treating constipation as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese medicines. The composition comprises the following components in parts by weight: 45 to 85 parts of Chinese pulsatilla root, 45 to 85 parts of oldenlandia diffusa, 45 to 85 parts of sculellaria barbata, 80 to 140 parts of Chinese actinidia root, 45 to 85 parts of trogopterus dung, 80 to 140 parts of coix seed, 80 to 140 parts of poria cocos, 80 to 140 parts of rhizoma pinellinae praeparata, 45 to 85 parts of pericarpium citri reticulatae, 60 to 100 parts of bighead atractylodes rhizome, 45 to 85 parts of endothelium corneum gigeriae galli, 60 to 100 parts of white hyacinth bean, 60 to 100 parts of dried ginger and 45 to 85 parts of liquorice. The traditional Chinese medicine composition has a good treatment effect on constipation caused by gastrointestinal tumors, is mild in medicine property, and is specially developed for patients with constipation caused by tumors.

The invention discloses a herbal nose-soothing health-care liquid and a preparation method thereof, and particularly relates to the technical field of rhinitis medicine preparation, and the herbal nose-soothing health-care liquid comprises the following components in parts by weight: 5-15 parts of angelica sinensis, 5-15 parts of salvia miltiorrhiza, 5-15 parts of ligusticum wallichii, 5-15 parts of sculellaria barbata, 5-15 parts of sambucus williamsii, 5-15 parts of pseudo-ginseng, 3-10 parts of magnolia flower, 3-10 parts of centipeda minima, 10-20 parts of astragalus membranaceus and 1-3 parts of borneol. According to the preparation method, medicinal materials with different properties are subjected to grouping treatment, graded extraction of components with different polarities is achieved through gradient variable-pressure decoction, the yield of active components is increased and the flavor of the product is improved through ultrasonic-assisted enzymolysis and solid-state segmented fermentation, accurate enrichment of target components is achieved through a membrane separation and resin adsorption combined technology, and the purity of the product is improved. The stability of volatile components is remarkably improved through a cyclodextrin inclusion technology, and the preparation is ensured to be uniformly dispersed through a high-shear emulsification technology.

The invention discloses a traditional Chinese medicine composition for treating metabolic dysfunction related steatohepatitis inflammatory cancer transformation. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 15-20 parts of fructus perillae, 12-18 parts of semen brassicae, 12-18 parts of semen raphani, 12-18 parts of radix astragali, 28-32 parts of herba scutellariae barbatae, 12-18 parts of rhizoma polygonati, 6-12 parts of gecko, 12-18 parts of radix polygoni multiflori and 4-8 parts of liquorice root. The traditional Chinese medicine composition disclosed by the invention can be used for inhibiting the transformation progress of mouse metabolic dysfunction related steatohepatitis cancer, reducing the number of liver tumors, reducing the maximum surface area of the tumors and reducing the mRNA (messenger ribonucleic acid) levels of related tumor markers Gpc3 and Ly6d. In addition, the lipid level of the mouse liver and serum can be remarkably reduced, the fatty degeneration degree of the mouse liver is improved, the ALT and AST levels of the serum are reduced, and liver injury is relieved. In addition, the invention further discloses medical application of the traditional Chinese medicine composition.

This invention belongs to the field of gastric disease treatment, specifically relating to a traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia and its preparation method. The traditional Chinese medicine composition for treating chronic atrophic gastritis with intestinal metaplasia comprises the following raw materials in parts by weight: Agrimonia pilosa 10-15 parts, Cyperus rotundus 8-10 parts, Scutellaria barbata 10-15 parts, Lobelia chinensis 10-15 parts, Patrinia scabiosaefolia 13-17 parts, Scutellaria baicalensis 7-11 parts, Hedyotis diffusa 10-15 parts, Prunella vulgaris 10-15 parts, Hedyotis diffusa 5-7 parts, Perilla frutescens 8-10 parts, Coptis chinensis 5-7 parts, Angelica sinensis 5-7 parts, etc. This invention focuses on the core pathogenesis of damp-heat in the spleen and stomach and stagnation of gastric collaterals. The Chinese herbal composition has the effects of clearing heat and removing dampness, regulating qi and harmonizing the stomach, nourishing blood and unblocking collaterals. Clinically, it can significantly improve the OLGA / OLGIM stage of patients with chronic atrophic gastritis with intestinal metaplasia, with a total effective rate of 65.1%, providing a safe and effective Chinese medicine solution for precancerous lesions of the stomach.

This invention discloses a traditional Chinese medicine composition for treating liver fibrosis with damp-heat toxicity, comprising the following raw materials in parts by weight: 20-30 parts of processed turtle shell, 18-25 parts of Oldenlandia diffusa, 11-15 parts of Curcuma zedoaria, 20-30 parts of processed Salvia miltiorrhiza (wine-processed), 14-20 parts of Scutellaria barbata, 11-15 parts of Epimedium, 10-15 parts of Artemisia capillaris, 14-20 parts of Sedum sarmentosum, 7-10 parts of Bupleurum chinense, 7-10 parts of Curcuma longa, 6-8 parts of dried ginger, 11-15 parts of stir-fried Atractylodes macrocephala, 18-25 parts of Astragalus membranaceus, 7-10 parts of Prunus persica, 8-12 parts of Schisandra chinensis, 4-6 parts of Panax notoginseng (powder), 14-20 parts of Poria cocos, and 3-5 parts of Cinnamomum cassia. This traditional Chinese medicine composition is developed based on the principles of TCM syndrome differentiation and treatment for liver fibrosis with damp-heat toxicity, and has the expected therapeutic effect on this condition.

The application discloses a traditional Chinese medicine composition for treating renal clear cell carcinoma and a preparation method and application thereof, and belongs to the technical field of medicines. The traditional Chinese medicine composition provided by the application comprises ginseng, astragalus, atractylodes, poria cocos, herba impatiens, oldenlandia, zedoary, dogwood fruit, ligustrum lucidum and prunella vulgaris. The traditional Chinese medicine composition provided by the application is scientific and reasonable in combination, can support healthy qi and eliminate pathogenic factors, clear heat and resolve toxins, activate blood and resolve stasis, and soften and resolve hard masses. The clinical experimental results show that the traditional Chinese medicine composition provided by the application can effectively treat renal clear cell carcinoma, and the treatment efficiency is better than that of the targeted drug sorafenib; and the medicine is safe, has no obvious toxic and side effects, and performs well in improving patient's traditional Chinese medicine syndromes, improving the quality of life and reducing the level of tumor markers. The application provides a new idea and method for treating renal clear cell carcinoma, and has significant clinical significance and important popularization value.

The application provides a traditional Chinese medicine preparation for treating diabetic nephropathy and a preparation method thereof, and belongs to the technical field of traditional Chinese medicine pharmacy. The traditional Chinese medicine preparation is prepared from traditional Chinese medicinal materials such as angelica, eucommia ulmoides, helicteres angustifolia, broussonetia papyrifera, radix paeoniae suffruticosae, curcuma longa, dendrobium, polygonatum, radix adnati, ligustrum lucidum, ipomoea purpurea, lagerstroemia indica, kochia scoparia, haes, pyrrosia lingua and herba barbatae, and has the effects of nourishing yin and kidney, promoting blood circulation to remove meridian obstruction and clearing heat and removing dampness. The traditional Chinese medicine preparation can up-regulate the expression levels of podocin and nephrin, inhibit inflammatory mediators, improve the blood sugar, urine protein, kidney function and kidney pathological injury of DN rats, provides a new idea for the treatment of diabetic nephropathy, and has a good development and application prospect.

This invention relates to a traditional Chinese medicine composition for treating primary liver cancer. The composition is made from the following raw materials in parts by weight: 25-30 parts of *Codonopsis pilosula*, 10-15 parts of *Cremastra appendiculata*, 15-20 parts of *Scutellaria barbata*, 20-25 parts of *Curcuma zedoaria*, 10-15 parts of *Polygonum cuspidatum*, and 5-10 parts of *Citrus reticulata*. This invention also provides applications of the traditional Chinese medicine composition. The "Liver-Clearing Formula" of this invention uses a combination of various traditional Chinese herbs, focusing on "damp-heat, phlegm, qi stagnation, and blood stasis." The six herbs are combined to both attack and tonify, supporting the body's resistance and eliminating pathogenic factors, aiming to achieve the goal of strengthening the body's resistance and reducing pathogenic factors, thus achieving the effects of clearing heat and dampness, promoting qi circulation, resolving phlegm, and breaking up blood stasis. This helps improve the patient's quality of life and prognosis. At the same time, the use of this traditional Chinese medicine is expected to reduce the toxicity and enhance the efficacy of Western medicine, reducing adverse reactions and achieving the best therapeutic effect.

The invention discloses traditional Chinese medicine granules for treating lung cancer and a preparation method thereof, and relates to the technical field of traditional Chinese medicine formulas. The invention discloses traditional Chinese medicine granules for treating lung cancer. The traditional Chinese medicine composition is prepared from aged black nightshade, marsdenia tenacissima, podophyllum, thunberg fritillary bulb, sculellaria barbata, oldenlandia diffusa, ganoderma applanatum, poria cocos, phellinus igniarius, honeysuckle, fructus forsythiae, dandelion, carbonized sanguisorba root, humifuse euphorbia herb, phyllanthus urinaria, folium isatidis, astragalus membranaceus, cottonrose hibiscus leaves, pericarpium trichosanthis, lance asiabell root, radix ranunculi ternati, spicate clerodendranthus herb, platycodon grandiflorum, aster, rhizoma atractylodis macrocephalae, herba cepbalanoplosis segeti, scorpio, turtle shell, radix ophiopogonis, codonopsis pilosula, radix pseudostellariae, momordica grosvenori, fig, Japanese ardisia herb and pyrrosia lingua. The traditional Chinese medicine has the effects of detoxifying, astringing to stop bleeding, astringing lung and improving symptoms, can finally reduce relapse, and is safe and reliable.

This invention belongs to the field of biopharmaceuticals and specifically discloses the preparation and application of a compound formulation of Hedyotis diffusa (5-30 parts), Scutellaria barbata (3-10 parts), Houttuynia cordata (3-6 parts), Ganoderma lucidum (2-4 parts), and astaxanthin for adjuvant tumor treatment. This compound is prepared by gradient decoction, nanoemulsification, and synergistic combination of ingredients, including Hedyotis diffusa (5-30 parts), Scutellaria barbata (3-10 parts), Houttuynia cordata (3-6 parts), Ganoderma lucidum (2-4 parts), and astaxanthin (0.5-1 parts). The combination of gradient temperature-controlled decoction and nanoemulsification (particle size 50-200 nm) significantly improves the bioavailability of heat-sensitive components (such as astaxanthin), allowing for the design of various dosage forms (tablets, capsules, and pills) to meet diverse clinical needs. Animal models have demonstrated that this compound enhances the efficacy of cytarabine and cisplatin while reducing chemotherapy toxicity (resumption of ALT / AST levels to normal). This invention combines multi-target anti-tumor and immunomodulatory properties with dosage form stability, providing an innovative solution for adjuvant tumor treatment.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to a TCM composition for treating tinnitus. Its ingredients include: vinegar-processed turtle shell, stir-fried jujube seed, anemarrhena rhizome, phellodendron bark, rehmannia root, white peony root, poria cocos, fleeceflower root vine, scutellaria barbata, oldenlandia diffusa, stir-fried atractylodes macrocephala, prunella vulgaris, and cicada slough. The TCM composition of this invention exhibits significant multi-dimensional beneficial effects in treating tinnitus. Compared with Western medicine treatments, it avoids the side effects such as low blood pressure, dizziness, drowsiness, and dry mouth associated with vasodilators and antidepressants, and overcomes the drawbacks of physical therapy, which only temporarily relieves symptoms and cannot cure the condition. It has the advantages of holistic conditioning and fewer side effects, providing a safe, effective, and comprehensive treatment plan for tinnitus patients, and has high clinical application value and promotional significance.

The invention relates to the technical field of traditional Chinese medicine preparations, and discloses a traditional Chinese medicine composition for treating hepatocellular carcinoma and application thereof, and the traditional Chinese medicine composition comprises the following components in parts by mass: 8-12 parts of ginseng, 13-17 parts of astragalus membranaceus, 8-12 parts of angelica sinensis, 8-12 parts of rhizoma polygonati, 8-12 parts of curcuma zedoary, 18-22 parts of oldenlandia diffusa, 8-12 parts of edible tulip, 3-6 parts of liquorice, 10-15 parts of sculellaria barbata and 5-10 parts of ganoderma lucidum spore powder. In the composition, the ginseng, the astragalus membranaceus and other medicines can enhance the immunity of the organism and protect hepatocytes, the curcuma zedoary, the oldenlandia diffusa and other medicines can directly inhibit tumor growth, and the curcuma zedoary and the oldenlandia diffusa and other medicines cooperate with each other, so that the composition not only improves the physique of a patient, but also plays an anti-tumor role, and accords with the pathogenesis characteristics of deficiency of vital qi and accumulation of pathogenic toxin of liver cancer.

The application discloses a traditional Chinese medicine composition for treating chronic atrophic gastritis with low-grade intra-epithelial neoplasia and a preparation method and application thereof. The traditional Chinese medicine composition is prepared from raw materials including radix astragali 10-15 parts, rhizoma atractylodis macrocephalae 8-10 parts, poria cocos 10-15 parts, pericarpium citri reticulatae 8-10 parts, rhizoma pinelliae 5-8 parts, cyperus rotundus 12-15 parts, panax notoginseng 3-5 parts, radix curcumae 10-12 parts, root of actinidia 15-20 parts, herba hedyotis diffusae 15-20 parts and herba scorpiuridis 10-15 parts. The traditional Chinese medicine composition has good effects of improving gastric mucosa atrophy and low-grade intra-epithelial neoplasia, and has important application prospects for development of drugs for simple chronic atrophic gastritis and chronic atrophic gastritis combined with low-grade intra-epithelial neoplasia.

The invention discloses a formula of a soaking solution for manual repairing and mounting of ancient calligraphy and paintings, and belongs to the technical field of protection and repairing of the ancient calligraphy and paintings. The soaking solution is prepared from the following raw materials in parts by weight: 1 part of spica prunellae, 1 to 4 parts of semen cassiae torae, 1 to 4 parts of fructus gleditsiae, 1 part of polygala tenuifolia, 1 part of periostracum cicadae, 1 to 4 parts of radix dipsaci, 1 part of sculellaria barbata, 1 part of rhizoma alismatis, 1 part of oyster, 1 part of bryozoatum, 0.5 part of liquorice root and a proper amount of root-free water. The soak solution formula for manual repairing and mounting of the ancient calligraphy and painting has the beneficial effects that the protection and repairing effects of the ancient calligraphy and painting can be remarkably improved. The formula has excellent decontamination and ink fixing performance, can effectively enhance the tensile strength and folding strength of paper, and meanwhile prevents the ink falling phenomenon of calligraphy and painting in the repairing process.

The invention relates to application of a traditional Chinese medicine composition in preparation of medicines for preventing or treating colon cancer. The traditional Chinese medicine composition comprises sculellaria barbata, astragalus membranaceus, angelica sinensis, nightshade, radix curcumae, red ginseng, duchesnea indica, saussurea involucrata, cyclea verticillata and salvia miltiorrhiza. The traditional Chinese medicine composition has a good prevention or treatment effect on colon cancer, specifically, proliferation of colon cancer cells is inhibited, a good prevention and treatment effect is shown in a colon cancer mouse model, and the size of mouse tumors can be remarkably reduced. The invention provides an effective strategy for prevention or treatment of colon cancer, and provides a new direction for application of the traditional Chinese medicine composition.

The invention discloses a compound anti-cancer Chinese patent medicine based on multi-target synergism and a preparation method thereof, and relates to the technical field of traditional Chinese medicine compound anti-tumor, the compound is composed of panax notoginseng saponins, ornithogalum caudatum saponin, lance asiabell root polysaccharide, sculellaria barbata flavone, oldenlandia diffusa polysaccharide, zedoary turmeric oil and ganoderma triterpenes according to a specific proportion. Wherein the monarch drug accounts for 30%-40% of cooked panax notoginseng saponins, the ministerial drug accounts for 20%-35% of ornithogalum caudatum saponin, the ministerial drug accounts for 5%-10% of the radix astragali extract, the adjuvant drugs account for 10%-15% of the adjuvant drugs and the conductant drugs account for 5%-10% of the conductant drugs, the nano-liposome co-loading technology is adopted, fat-soluble components are loaded on a liposome hydrophobic layer, water-soluble components are loaded on a hydrophilic layer, the preparation effect that the encapsulation efficiency is larger than or equal to 95%, and the particle size is 80 + / -5 nm is achieved, and the preparation effect is good. Trehalose is added as a freeze-drying protective agent, so that the stability reaches 36 months, and the freeze-dried powder can be used for solid tumor treatment and postoperative recurrence prevention, is especially suitable for chemotherapy of drug-resistant tumors, and widens the application range of anti-tumor traditional Chinese medicines.

The invention discloses an anti-breast cancer traditional Chinese medicine compound preparation as well as a preparation method and application thereof. The anti-breast cancer traditional Chinese medicine compound preparation is prepared from the following raw material medicines in parts by weight: 25-35 parts of ganoderma lucidum spore powder, 10-20 parts of edible tulip, 10-20 parts of sculellaria barbata, 20-30 parts of oldenlandia diffusa, 8-12 parts of detoxified nidus vespae, 20-30 parts of selfheal, 10-20 parts of akebia fruit and 15-25 parts of uniflower swisscentaury root. Ganoderma lucidum spore powder is used as a monarch drug instead of a tonic drug, so that the risk of excessive activation of immunity is avoided; the retention rate of triterpenes is greater than or equal to 95% and the yield of polysaccharides is greater than or equal to 15% through a segmented extraction Establishing a nidus vespae detoxification process and a nidus vespae oil limit standard; by removing tumor-promoting risk medicinal materials, introducing active synergistic components and innovating a toxicity control process, the anti-tumor activity and medication safety are remarkably improved, and the composition is suitable for adjuvant therapy of breast cancer.

The present application relates to the field of traditional Chinese medicine, and is a traditional Chinese medicine composition for eliminating tumors and a preparation method thereof. Nowadays, the incidence of tumors is becoming younger and younger, and the current treatment mainly uses western medicines, which have large side effects and can cause other adverse reactions if taken for a long time. The present application is composed of the following drugs: Herba Lophatheri 30g, Radix Sophorae Tonkinensis 6g, Prunella vulgaris 15g, Berberis dictyophylla 15g, Fructus Lycii 12g, Herba Epimedium 30g, Radix Ginseng 9g, Radix Astragali 30g, Spatholobi Caulis 15g, Ganoderma lucidum 12g, Rhizoma Polygonati 30g, Rhizoma Corydalis 10g, Taxus chinensis var. mairei 9g. Compared with western medicine preparations, the present application has fast curative effect and small side effects. It has certain protective effect on WBC reduction caused by chemotherapy drugs. When used with chemotherapy drugs, the present application can significantly increase the effect of chemotherapy (P<0.01), so the dosage of chemotherapy drugs can be correspondingly reduced.

The application provides a compound paclitaxel broad-spectrum anticancer traditional Chinese medicine preparation and a preparation method thereof, and belongs to the technical field of traditional Chinese medicines. The compound paclitaxel broad-spectrum anticancer traditional Chinese medicine preparation is prepared from the following components in a mass fraction: 0.5-2.0 parts of paclitaxel powder with a purity of 99%, 18-30 parts of Herba Lysimachiae, 18-30 parts of Herba Impatientis, 18-30 parts of Radix Scrophulariae, 14-25 parts of Radix Curcumae, 14-25 parts of Radix Pini Strobil, 14-25 parts of Gynostemma pentaphyllum, 14-25 parts of Citrus medica, 10-18 parts of Radix Paeoniae Alba, 10-18 parts of Radix Paeoniae Rubra, 10-18 parts of Radix Rabdosiae, 6-12 parts of Fructus Schisandrae, 6-12 parts of Lumbricus, and 6-12 parts of Radix Glycyrrhizae. The compound paclitaxel broad-spectrum anticancer traditional Chinese medicine preparation can not only significantly inhibit the growth of tumor cells on a lung cancer patient, but also significantly reduce bone marrow suppression and immune function damage caused by paclitaxel.

The invention provides a traditional Chinese medicine composition for treating diabetes and / or diabetic complications, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition comprises calculus bovis factitius, rhizoma atractylodis, almond, radix paeoniae rubra, ligusticum wallichii, salvia miltiorrhiza, semen momordicae, elecampane, ginseng, penis et testis cervi, hippocampus, syngnathus, eucommia ulmoides, fructus psoraleae, notopterygium root, radix clematidis, sculellaria barbata, semen cassiae, curcuma zedoary, rhizoma sparganii, radix trichosanthis, felwort and astragalus membranaceus. The traditional Chinese medicine composition has the effects of promoting the production of body fluid to quench thirst, clearing away heat and toxic materials and invigorating spleen to eliminate dampness through the synergistic effect of the medicines, has a good treatment effect on type I diabetes mellitus, type II diabetes mellitus and diabetic complications (lactic acidosis, ketoacidosis and symmetric distal polyneuritis caused by ketoacidosis), has a clinical total effective rate of 91.88%, does not have toxic or side effects, and is suitable for clinical application. The preparation method is simple, and the use is convenient.

The invention relates to the technical field of nano material preparation, and particularly discloses a preparation method of nano micro-powder based on traditional Chinese medicine and sea salt composite smelting purification, the method comprises the following steps: according to the principle of monarch, minister, assistant and guide in traditional Chinese medicine, combining astragalus membranaceus, lucid ganoderma, sculellaria barbata, oldenlandia diffusa, salvia miltiorrhiza, ligusticum wallichii and deep sea salt; adopting supercritical COextraction combined with vacuum freeze drying to obtain traditional Chinese medicine extract powder; a high-purity sea salt mineral concentrate is obtained through electrolytic purification and molecular distillation; the two components are mixed according to a ratio of 3: 1 to 5: 1, the mixture is subjected to high-energy ball milling and jet milling to prepare composite micro-powder with a particle size of 50-200 nanometers, and a quality control system covering characters, identification, content determination and stability is established. According to the technical scheme, efficient compounding of traditional Chinese medicine effective components and sea salt mineral substances is achieved, the bioavailability, the treatment effect and the product stability of the medicine are remarkably improved, and a safe and efficient nano traditional Chinese medicine novel dosage form is provided for treatment of tumors and chronic diseases.

The invention discloses a traditional Chinese medicine composition for treating nasopharynx cancer and a preparation method of a nano freeze-dried tablet of the traditional Chinese medicine composition. The traditional Chinese medicine composition is characterized by being prepared from the following raw materials in parts by weight: 25-35 parts of astragalus membranaceus, 25-35 parts of ganoderma lucidum spore powder, 25-35 parts of centipeda minima, 25-35 parts of cortex juglandis mandshuricae, 8-12 parts of dried toad skin, 2-4 parts of centipede, 1-3 parts of gecko, 10-20 parts of ligusticum wallichii, 10-20 parts of sculellaria barbata, 25-35 parts of oldenlandia diffusa, 10-20 parts of paris polyphylla, 5-10 parts of liquorice, 8-12 parts of magnolia flower and 5-10 parts of fresh ginger. The nasopharynx cancer can be treated through the traditional Chinese medicine, so that the defects of operative treatment, radiotherapy and chemical treatment are overcome, and the treatment effect is improved.

The invention discloses health-care tea for prostate and a preparation method thereof. The health-care tea for prostate comprises the following raw material components in parts by weight: 10-20 parts of sculellaria barbata, 10-20 parts of herba violae, 15-25 parts of purslane, 10-20 parts of radix paeoniae rubra, 150-250 parts of poria cocos, 150-250 parts of coix seeds and 8-12 parts of triquetrous tadehagi herb. The peony flower and bud tea is prepared from 80-120 parts of dried peony flower and bud, 100-200 parts of haw slices, 20-40 parts of snow pear freeze-dried powder, 10-20 parts of camellia pollen and 50-100 parts of green tea or oolong tea. Through scientific compatibility, medicinal materials capable of clearing heat and promoting diuresis, promoting blood circulation to remove blood stasis and tonifying spleen and kidney are combined with characteristic plant raw materials, through an optimized preparation process, prostate health is conditioned in a multi-target mode, and meanwhile the prostate health conditioning tea has excellent taste and stability.

This invention relates to the field of traditional Chinese medicine composition technology, and in particular to a traditional Chinese medicine composition for treating lung cancer and its preparation method, comprising composition one, composition two, and composition three; composition one, by weight parts, comprises: Astragalus membranaceus 20-45 parts, Polygonatum odoratum 15-30 parts, Ophiopogon japonicus 8-18 parts, Coix lacryma-jobi 20-45 parts, Phragmites communis 20-45 parts, and Glycyrrhiza uralensis 3-6 parts; composition two, by weight parts, comprises: Clematis armandii 9-15 parts, Actinidia chinensis root 15-30 parts, Scutellaria barbata 10-22 parts, Pinellia ternata 6-13 parts, Fritillaria thunbergii 6-13 parts, and Citrus reticulata peel 6-13 parts; composition three, by weight parts, comprises: Buthus martensii 3-8 parts. The traditional Chinese medicine composition prepared by this invention has the effects of invigorating qi and nourishing yin, clearing heat and detoxifying, resolving phlegm and dissipating nodules, and promoting blood circulation and unblocking collaterals. It overcomes the technical problems of existing anti-lung cancer chemotherapy drugs having large toxic side effects and easily developing drug resistance, as well as the limited anti-lung cancer effects of existing single or simple compound traditional Chinese medicines, and the lack of optimization in compatibility and process.